Myelin-phagocytosing macrophages modulate autoreactive T cell proliferation

Journal of Neuroinflammation

Volumn 8, Issue , 2011, Pages

  Bogie, Jeroen F J ^a   Stinissen, Piet ^a   Hellings, Niels ^a   Hendriks, Jerome J A ^a  

^a HASSELT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN; NITRIC OXIDE; OVALBUMIN; T LYMPHOCYTE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; MYELIN BASIC PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CELL CONTACT; FEMALE; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PROTEIN FUNCTION; RAT; T LYMPHOCYTE; ANIMAL; BRAIN; CELL CULTURE; CELL PROLIFERATION; COCULTURE; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; LEWIS RAT; LYMPHOCYTE ACTIVATION; METABOLISM; MYELIN SHEATH; PATHOLOGY; PERITONEUM MACROPHAGE; SPINAL CORD;

ANIMALS; BRAIN; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; FEMALE; LYMPHOCYTE ACTIVATION; MACROPHAGES, PERITONEAL; MYELIN BASIC PROTEINS; MYELIN SHEATH; NITRIC OXIDE; OVALBUMIN; PHAGOCYTOSIS; RATS; RATS, INBRED LEW; RECEPTORS, ANTIGEN, T-CELL; SPINAL CORD; T-LYMPHOCYTES;

EID: 79960577501     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-8-85     Document Type: Article

References (78)

1. Hellings N, Raus J, Stinissen P. Insights into the immunopathogenesis of multiple sclerosis. Immunol Res 2002, 25:27-51. 10.1385/IR:25:1:27, 11868933.
2. Vanderlocht J, Hellings N, Hendriks JJ, Stinissen P. The ambivalent nature of T-cell infiltration in the central nervous system of patients with multiple sclerosis. Crit Rev Immunol 2007, 27:1-13.
3. McFarland HF, Martin R. Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol 2007, 8:913-919. 10.1038/ni1507, 17712344.
4. Goverman J. Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 2009, 9:393-407. 10.1038/nri2550, 2813731, 19444307.
5. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998, 338:278-285. 10.1056/NEJM199801293380502, 9445407.
6. Huitinga I, van Rooijen N, de Groot CJ, Uitdehaag BM, Dijkstra CD. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 1990, 172:1025-1033. 10.1084/jem.172.4.1025, 2188611, 2145387.
7. Huitinga I, Ruuls SR, Jung S, van Rooijen N, Hartung HP, Dijkstra CD. Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats. Clin Exp Immunol 1995, 100:344-351. 1534326, 7743675.
8. Tran EH, Hoekstra K, van RN, Dijkstra CD, Owens T. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J Immunol 1998, 161:3767-3775.
9. Williams K, Ulvestad E, Waage A, Antel JP, McLaurin J. Activation of adult human derived microglia by myelin phagocytosis in vitro. J Neurosci Res 1994, 38:433-443. 10.1002/jnr.490380409, 7932874.
10. Mosley K, Cuzner ML. Receptor-mediated phagocytosis of myelin by macrophages and microglia: effect of opsonization and receptor blocking agents. Neurochem Res 1996, 21:481-487. 10.1007/BF02527713, 8734442.
11. van der Laan LJ, Ruuls SR, Weber KS, Lodder IJ, Dopp EA, Dijkstra CD. Macrophage phagocytosis of myelin in vitro determined by flow cytometry: phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-alpha and nitric oxide. J Neuroimmunol 1996, 70:145-152. 10.1016/S0165-5728(96)00110-5, 8898723.
12. Boven LA, van Meurs M, van Zwam M, Wierenga-Wolf A, Hintzen RQ, Boot RG, et al. Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain 2006, 129:517-526.
13. Liu Y, Hao W, Letiembre M, Walter S, Kulanga M, Neumann H, et al. Suppression of microglial inflammatory activity by myelin phagocytosis: role of p47-PHOX-mediated generation of reactive oxygen species. J Neurosci 2006, 26:12904-12913. 10.1523/JNEUROSCI.2531-06.2006, 17167081.
14. van Rossum D, Hilbert S, Strassenburg S, Hanisch UK, Bruck W. Myelin-phagocytosing macrophages in isolated sciatic and optic nerves reveal a unique reactive phenotype. Glia 2008, 56:271-283. 10.1002/glia.20611, 18069669.
15. Sun X, Wang X, Chen T, Li T, Cao K, Lu A, et al. Myelin activates FAK/Akt/NF-kappaB pathways and provokes CR3-dependent inflammatory response in murine system. PLoS One 2010, 5:e9380. 10.1371/journal.pone.0009380, 2826415, 20186338.
16. Glim JE, Vereyken EJ, Heijnen DA, Vallejo JJ, Dijkstra CD. The release of cytokines by macrophages is not affected by myelin ingestion. Glia 2010, 58:1928-1936. 10.1002/glia.21062, 20830806.
17. Piani D, Frei K, Do KQ, Cuenod M, Fontana A. Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci Lett 1991, 133:159-162. 10.1016/0304-3940(91)90559-C, 1687755.
18. Flavin MP, Coughlin K, Ho LT. Soluble macrophage factors trigger apoptosis in cultured hippocampal neurons. Neuroscience 1997, 80:437-448. 10.1016/S0306-4522(97)00078-X, 9284347.
19. Hendriks JJ, Teunissen CE, de Vries HE, Dijkstra CD. Macrophages and neurodegeneration. Brain Res Brain Res Rev 2005, 48:185-195.
20. Barnett MH, Henderson AP, Prineas JW. The macrophage in MS: just a scavenger after all? Pathology and pathogenesis of the acute MS lesion. Mult Scler 2006, 12:121-132. 10.1191/135248506ms1304rr, 16629415.
21. Pineau I, Lacroix S. Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J Comp Neurol 2007, 500:267-285. 10.1002/cne.21149, 17111361.
22. Miller E, Mrowicka M, Zolynski K, Kedziora J. [Oxidative stress in multiple sclerosis]. Pol Merkur Lekarski 2009, 27:499-502.
23. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 2007, 204:3037-3047. 10.1084/jem.20070885, 2118517, 18025128.
24. Umemura N, Saio M, Suwa T, Kitoh Y, Bai J, Nonaka K, et al. Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics. J Leukoc Biol 2008, 83:1136-1144. 10.1189/jlb.0907611, 18285406.
25. Morell P, Barrett CV, Mason JL, Toews AD, Hostettler JD, Knapp GW, et al. Gene expression in brain during cuprizone-induced demyelination and remyelination. Mol Cell Neurosci 1998, 12:220-227. 10.1006/mcne.1998.0715, 9828087.
26. Arnett HA, Wang Y, Matsushima GK, Suzuki K, Ting JP. Functional genomic analysis of remyelination reveals importance of inflammation in oligodendrocyte regeneration. J Neurosci 2003, 23:9824-9832.
27. Li WW, Setzu A, Zhao C, Franklin RJ. Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination. J Neuroimmunol 2005, 158:58-66. 10.1016/j.jneuroim.2004.08.011, 15589038.
28. Miller RH. Contact with central nervous system myelin inhibits oligodendrocyte progenitor maturation. Dev Biol 1999, 216:359-368. 10.1006/dbio.1999.9466, 10588885.
29. Kotter MR, Zhao C, van Rooijen N, Franklin RJ. Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiol Dis 2005, 18:166-175. 10.1016/j.nbd.2004.09.019, 15649707.
30. Kotter MR, Li WW, Zhao C, Franklin RJ. Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci 2006, 26:328-332. 10.1523/JNEUROSCI.2615-05.2006, 16399703.
31. Gredler V, Ebner S, Schanda K, Forstner M, Berger T, Romani N, et al. Impact of human myelin on the maturation and function of human monocyte-derived dendritic cells. Clin Immunol 2010, 134:296-304. 10.1016/j.clim.2009.11.003, 19945918.
32. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005, 23:683-747. 10.1146/annurev.immunol.23.021704.115707, 15771584.
33. de Vos AF, van Meurs M, Brok HP, Boven LA, Hintzen RQ, van d V, et al. Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs. J Immunol 2002, 169:5415-5423.
34. Fabriek BO, Zwemmer JN, Teunissen CE, Dijkstra CD, Polman CH, Laman JD, et al. In vivo detection of myelin proteins in cervical lymph nodes of MS patients using ultrasound-guided fine-needle aspiration cytology. J Neuroimmunol 2005, 161:190-194. 10.1016/j.jneuroim.2004.12.018, 15748959.
35. van Zwam M, Huizinga R, Melief MJ, Wierenga-Wolf AF, van Meurs M, Voerman JS, et al. Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE. J Mol Med 2009, 87:273-286. 10.1007/s00109-008-0421-4, 19050840.
36. Karman J, Ling C, Sandor M, Fabry Z. Initiation of immune responses in brain is promoted by local dendritic cells. J Immunol 2004, 173:2353-2361.
37. van Zwam M, Wierenga-Wolf AF, Melief MJ, Schrijver B, Laman JD, Boven LA. Myelin ingestion by macrophages promotes their motility and capacity to recruit myeloid cells. J Neuroimmunol 2010, 225:112-117. 10.1016/j.jneuroim.2010.04.021, 20605225.
38. Hendriks JJ, Slaets H, Carmans S, de Vries HE, Dijkstra CD, Stinissen P, et al. Leukemia inhibitory factor modulates production of inflammatory mediators and myelin phagocytosis by macrophages. J Neuroimmunol 2008, 204:52-57. 10.1016/j.jneuroim.2008.07.015, 18771807.
39. Norton WT, Poduslo SE. Myelination in rat brain: changes in myelin composition during brain maturation. J Neurochem 1973, 21:759-773. 10.1111/j.1471-4159.1973.tb07520.x, 4754856.
40. Vandenbark AA, Gill T, Offner H. A myelin basic protein-specific T lymphocyte line that mediates experimental autoimmune encephalomyelitis. J Immunol 1985, 135:223-228.
41. Lescano-De-Souza A, Curi R. Cholesterol inhibits glutamine metabolism in LLC WRC256 tumour cells but does not affect it in lymphocytes: possible implications for tumour cell proliferation. Cell Biochem Funct 1999, 17:223-228. 10.1002/(SICI)1099-0844(199912)17:4<223::AID-CBF832>3.0.CO;2-8, 10587609.
42. Nishiyama A, Cavaglieri CR, Curi R, Calder PC. Arachidonic acid-containing phosphatidylcholine inhibits lymphocyte proliferation and decreases interleukin-2 and interferon-gamma production from concanavalin A-stimulated rat lymphocytes. Biochim Biophys Acta 2000, 1487:50-60.
43. van der Veen RC, Dietlin TA, Dixon GJ, Gilmore W. Macrophage-derived nitric oxide inhibits the proliferation of activated T helper cells and is induced during antigenic stimulation of resting T cells. Cell Immunol 2000, 199:43-49. 10.1006/cimm.1999.1597, 10675274.
44. Peres CM, Otton R, Curi R. Modulation of lymphocyte proliferation by macrophages and macrophages loaded with arachidonic acid. Cell Biochem Funct 2005, 23:373-381. 10.1002/cbf.1249, 16170829.
45. Denham S, Rowland IJ. Inhibition of the reactive proliferation of lymphocytes by activated macrophages: the role of nitric oxide. Clin Exp Immunol 1992, 87:157-162. 1554247, 1733631.
46. Bingisser RM, Tilbrook PA, Holt PG, Kees UR. Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway. J Immunol 1998, 160:5729-5734.
47. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 1999, 189:1363-1372. 10.1084/jem.189.9.1363, 2193062, 10224276.
48. Rodriguez PC, Zea AH, DeSalvo J, Culotta KS, Zabaleta J, Quiceno DG, et al. L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes. J Immunol 2003, 171:1232-1239.
49. Rodriguez PC, Quiceno DG, Zabaleta J, Ortiz B, Zea AH, Piazuelo MB, et al. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res 2004, 64:5839-5849. 10.1158/0008-5472.CAN-04-0465, 15313928.
50. Zea AH, Rodriguez PC, Atkins MB, Hernandez C, Signoretti S, Zabaleta J, et al. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res 2005, 65:3044-3048.
51. Mahidhara RS, Hoffman RA, Huang S, Wolf-Johnston A, Vodovotz Y, Simmons RL, et al. Nitric oxide-mediated inhibition of caspase-dependent T lymphocyte proliferation. J Leukoc Biol 2003, 74:403-411. 10.1189/jlb.0602293, 12949244.
52. Ahvazi BC, Jacobs P, Stevenson MM. Role of macrophage-derived nitric oxide in suppression of lymphocyte proliferation during blood-stage malaria. J Leukoc Biol 1995, 58:23-31.
53. Albina JE, Abate JA, Henry WL. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. Role of IFN-gamma in the induction of the nitric oxide-synthesizing pathway. J Immunol 1991, 147:144-148.
54. Isobe K, Nakashima I. Feedback suppression of staphylococcal enterotoxin-stimulated T-lymphocyte proliferation by macrophages through inductive nitric oxide synthesis. Infect Immun 1992, 60:4832-4837. 258238, 1398994.
55. Shimizu T, Cai S, Tomioka H. Roles of reactive nitrogen intermediates and transforming growth factor-beta produced by immunosuppressive macrophages in the expression of suppressor activity against T cell proliferation induced by TCR stimulation. Cytokine 2005, 30:7-13. 10.1016/j.cyto.2004.12.016, 15784407.
56. Hamilton MJ, Antignano F, von RA, Boucher JL, Bennewith KL, Krystal G. TLR agonists that induce IFN-beta abrogate resident macrophage suppression of T cells. J Immunol 2010, 185:4545-4553. 10.4049/jimmunol.1002045, 20844190.
57. Carrasco YR, Batista FD. B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node. Immunity 2007, 27:160-171. 10.1016/j.immuni.2007.06.007, 17658276.
58. Junt T, Moseman EA, Iannacone M, Massberg S, Lang PA, Boes M, et al. Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature 2007, 450:110-114. 10.1038/nature06287, 17934446.
59. Phan TG, Grigorova I, Okada T, Cyster JG. Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells. Nat Immunol 2007, 8:992-1000. 10.1038/ni1494, 17660822.
60. Phan TG, Green JA, Gray EE, Xu Y, Cyster JG. Immune complex relay by subcapsular sinus macrophages and noncognate B cells drives antibody affinity maturation. Nat Immunol 2009, 10:786-793. 10.1038/ni.1745, 2776777, 19503106.
61. Barral P, Polzella P, Bruckbauer A, van Rooijen N, Besra GS, Cerundolo V, et al. CD169(+) macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes. Nat Immunol 2010, 11:303-312. 10.1038/ni.1853, 2923071, 20228797.
62. O'Brien NC, Charlton B, Cowden WB, Willenborg DO. Nitric oxide plays a critical role in the recovery of Lewis rats from experimental autoimmune encephalomyelitis and the maintenance of resistance to reinduction. J Immunol 1999, 163:6841-6847.
63. Kahl KG, Zielasek J, Uttenthal LO, Rodrigo J, Toyka KV, Schmidt HH. Protective role of the cytokine-inducible isoform of nitric oxide synthase induction and nitrosative stress in experimental autoimmune encephalomyelitis of the DA rat. J Neurosci Res 2003, 73:198-205. 10.1002/jnr.10649, 12836162.
64. Xu LY, Yang JS, Link H, Xiao BG. SIN-1, a nitric oxide donor, ameliorates experimental allergic encephalomyelitis in Lewis rats in the incipient phase: the importance of the time window. J Immunol 2001, 166:5810-5816.
65. Cowden WB, Cullen FA, Staykova MA, Willenborg DO. Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE. J Neuroimmunol 1998, 88:1-8. 10.1016/S0165-5728(98)00040-X, 9688317.
66. Staykova MA, Paridaen JT, Cowden WB, Willenborg DO. Nitric oxide contributes to resistance of the Brown Norway rat to experimental autoimmune encephalomyelitis. Am J Pathol 2005, 166:147-157. 10.1016/S0002-9440(10)62240-7, 1602296, 15632008.
67. Valledor AF, Ricote M. Nuclear receptor signaling in macrophages. Biochem Pharmacol 2004, 67:201-212. 10.1016/j.bcp.2003.10.016, 14698033.
68. Hong C, Tontonoz P. Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors. Curr Opin Genet Dev 2008, 18:461-467. 10.1016/j.gde.2008.07.016, 2641014, 18782619.
69. Bensinger SJ, Tontonoz P. Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature 2008, 454:470-477. 10.1038/nature07202, 18650918.
70. Wang PY, Kitchens RL, Munford RS. Phosphatidylinositides bind to plasma membrane CD14 and can prevent monocyte activation by bacterial lipopolysaccharide. J Biol Chem 1998, 273:24309-24313. 10.1074/jbc.273.38.24309, 9733716.
71. Jou I, Lee JH, Park SY, Yoon HJ, Joe EH, Park EJ. Gangliosides trigger inflammatory responses via TLR4 in brain glia. Am J Pathol 2006, 168:1619-1630. 10.2353/ajpath.2006.050924, 1606595, 16651628.
72. Jeon SB, Yoon HJ, Park SH, Kim IH, Park EJ. Sulfatide, a major lipid component of myelin sheath, activates inflammatory responses as an endogenous stimulator in brain-resident immune cells. J Immunol 2008, 181:8077-8087.
73. Lee C, An HJ, Kim JL, Lee H, Paik SG. Inhibitory effect of a phosphatidyl ethanolamine derivative on LPS-induced sepsis. Mol Cells 2009, 27:251-255. 10.1007/s10059-009-0049-4, 19277509.
74. Mantovani A, Sica A, Locati M. Macrophage polarization comes of age. Immunity 2005, 23:344-346. 10.1016/j.immuni.2005.10.001, 16226499.
75. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005, 5:953-964. 10.1038/nri1733, 16322748.
76. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008, 8:958-969. 10.1038/nri2448, 2724991, 19029990.
77. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009, 27:451-483. 10.1146/annurev.immunol.021908.132532, 19105661.
78. Ghosn EE, Cassado AA, Govoni GR, Fukuhara T, Yang Y, Monack DM, et al. Two physically, functionally, and developmentally distinct peritoneal macrophage subsets. Proc Natl Acad Sci USA 2010, 107:2568-2573. 10.1073/pnas.0915000107, 2823920, 20133793.